Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × relatlimab × Clear all

NCT05704933 2025-10-20

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Phase EARLY_PHASE1 Completed

CNSDermatologic

Brain Neoplasms, Melanoma